In Brief: LocalMed/Cordis
This article was originally published in The Gray Sheet
Executive Summary
LocalMed/Cordis: Companies ink agreement under which LocalMed will provide its StentaSleeve stent delivery system to Johnson & Johnson subsidiary Cordis for use in implanting Cordis' Palmaz-Schatz coronary stent. The deal calls for Cordis to provide "research and development funding" for StentaSleeve, which is based on the over-the-balloon technology employed in LocalMed's InfusaSleeve drug delivery catheter. StentaSleeve enables stent delivery with a single high-pressure balloon, LocalMed says...